Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process
Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process. // eClinicalMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2589537026005316?dgcid=rss_sd_all
Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process. eClinicalMedicine. https://www.sciencedirect.com/science/article/pii/S2589537026005316?dgcid=rss_sd_all
“Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process.” eClinicalMedicine.
@article{article97861,
title = {Defining the clinical benefits of disease-modifying therapy in people living with spinal muscular atrophy who require permanent ventilation: a UK-based modified Delphi consensus process},
journal = {eClinicalMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2589537026005316?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...